| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | thapsigargin | GDSC1000 | pan-cancer | AAC | 0.052 | 0.1 |
| mRNA | Obatoclax Mesylate | GDSC1000 | pan-cancer | AAC | 0.051 | 0.1 |
| mRNA | BRD8958 | CTRPv2 | pan-cancer | AAC | 0.056 | 0.1 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | 0.047 | 0.1 |
| mRNA | linifanib | GDSC1000 | pan-cancer | AAC | 0.051 | 0.1 |
| mRNA | BRD-K01737880 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.1 |
| mRNA | ISOX | CTRPv2 | pan-cancer | AAC | 0.045 | 0.1 |
| mRNA | NVP-ADW742 | CTRPv2 | pan-cancer | AAC | 0.049 | 0.2 |
| mRNA | SN-38 | GDSC1000 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | CD-1530 | CTRPv2 | pan-cancer | AAC | 0.053 | 0.2 |